secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001193125-23-161600
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Frequency Therapeutics cuts workforce by 55%, extends CFO severance terms
-------------------------------------------------------------------------

- Workforce reduction of approximately 55%; severance costs estimated at $1.16M.
- Reduction to be completed by June 9, 2023; Board approved May 31, 2023.
- CFO Richard Mitrano's severance extended: non-CIC from 6 to 9 months, CIC from 9 to 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523161600/0001193125-23-161600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523161600/d390817d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-161600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer